secwatch.observer — SEC 8-K summary
======================================

Issuer:     CASTLE BIOSCIENCES INC (CSTL)
CIK:        0001447362
Form:       8-K
Filed at:   2025-05-23T23:59:59+00:00
Accession:  0001447362-25-000085
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 3.03, 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Castle Biosciences shareholders approve officer exculpation charter amendment; re-elect directors
--------------------------------------------------------------------------------

- Stockholders approved amendment to certificate of incorporation to limit officer liability per Delaware law, effective May 22, 2025.
- Re-elected Class III directors Kimberlee S. Caple, G. Bradley Cole, and Derek J. Maetzold to terms expiring 2028.
- Ratified KPMG as independent auditor for FY2025 with 23.7M votes for, 20.8K against.
- Approved advisory say-on-pay proposal with 20.0M for, 1.3M against, 43K abstain.
- All proposals passed with overwhelming support; broker non-votes noted for director election and say-on-pay.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1447362/000144736225000085/0001447362-25-000085-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1447362/000144736225000085/cstl-20250522.htm
  HTML page:      https://secwatch.observer/filing/0001447362-25-000085

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer